Actively Recruiting
Towards Digital Management of Paediatric Asthma
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-05-06
50
Participants Needed
1
Research Sites
57 weeks
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their daily prevention medication and their rescue medication for asthma symptoms. If a child misses several days of prevention medication or uses their rescue inhaler frequently, their doctor receives an alert and can schedule a video consultation to adjust their treatment. Fifty children aged 4-12 years with asthma will participate for 8 months, with half using this digital system and half receiving usual care. The study will measure whether this new approach is practical and acceptable to families and doctors, and will look at its effects on asthma control, quality of life, and healthcare use. The results will help design a larger study to fully test if this digital approach could improve asthma care for children.
CONDITIONS
Official Title
Towards Digital Management of Paediatric Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 4 to 12 years with asthma diagnosed by a physician
- Followed up for asthma by a pediatrician or pediatric pulmonologist
- Asthma severity corresponding to GINA grades 2, 3, or 4
- Uses controller and reliever treatments via pressurized metered-dose inhalers (p-MDIs)
- Has social security coverage
- Parents or legal guardians have given written informed consent
- Parents or legal guardians have a compatible smartphone at home
- Parents or legal guardians can understand the use of the mobile app and digital inhalers according to the investigator
You will not qualify if you...
- Having another illness that could interfere with study evaluation (e.g., bronchopulmonary dysplasia, cystic fibrosis)
- Parents or legal guardians unable to understand the study purpose or give consent as judged by the investigator
- Receiving State Medical Aid
- Did not use the system within 15 days after the inclusion visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hôpital Necker Enfants Malades AP-HP
Paris, France, 75015
Actively Recruiting
Research Team
D
David DUMMOND, MD, PhD
CONTACT
S
sarah BOUCHARD, Project manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here